தடுப்பு மருந்துகள் உற்பத்தி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தடுப்பு மருந்துகள் உற்பத்தி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தடுப்பு மருந்துகள் உற்பத்தி Today - Breaking & Trending Today

Britain is a world leader in vaccines – let's do the same with microchips


Britain is a world leader in vaccines – let s do the same with microchips 
Newport Wafer in south Wales, the largest UK manufacturer, is already expanding its capacity - but we could be doing a lot more
1 May 2021 • 5:00am
The car plants are halting production. The tech giants are postponing product launches. New computers and tablets won’t be available very soon, and before long there will be a waiting list if you order a new fridge or TV.
A critical shortage of microchips is bringing the global economy to a halt, and revealing our dependence on the most crucial cog of the industrial machine. We can debate endlessly the reasons for that, from the closure of the Suez Canal, to the booming market for devices during lockdown. But the most important question is: how do we plan to fix it? ....

United Kingdom , United States , South Korea , Bruxelles Capitale , European Commission , Semiconductor Industry Association , European Union , Innovation Centre In Oxfordshire , Suez Canal , Galaxy Note , South Wales , Vaccines Manufacturing , Innovation Centre , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , ப்ரூக்ஸெல்ஸ் தலைநகரம் , ஐரோப்பிய தரகு , குறைக்கடத்தி தொழில் சங்கம் , ஐரோப்பிய தொழிற்சங்கம் , கண்டுபிடிப்பு மையம் இல் ஆக்ஸ்ஃபர்ட்‌ஶைர் , ஸூயெஸ் கால்வாய் , விண்மீன் குறிப்பு , தெற்கு வேல்ஸ் , தடுப்பு மருந்துகள் உற்பத்தி , கண்டுபிடிப்பு மையம் ,

Investegate |Oxford Biomedica PLC Announcements | Oxford Biomedica PLC: Full year results


 

I am truly proud of the Group s achievements over the period. We not only secured major new partnerships, brought the Oxbox manufacturing facility online in record time and responded to the challenges of the pandemic, but the team has also been able to rapidly work with AstraZeneca to provide a vaccine solution for COVID-19. This is a true testament to the world-class calibre and dedication of our staff in the year that the Group also gained entry to the FTSE250. Looking to the future, with the continued tide of growth in cell and gene therapy, coupled with the Group s leadership position in the lentiviral vector field, we are well positioned to advance both our own proprietary pipeline and that of our current and future partners programmes. ....

United Kingdom , Sam Rasty , Pierre Fabre , Mary Jane Elliott Matthew Neal , Stuart Paynter , Andrew Heath , Roch Doliveux , Oxford Astrazeneca , Oxford Biomedica Lentivector , John Dawson , Martin Diggle , Oxford Biomedica , Bristol Myers Squibb , Lorenzo Tallarigo , Juno Bristol Myers Squibb , Dame Kay Davies , Manufacturing Organisation , Contract Development , Oxford University Jenner Institute , Research Collaborations , Senior Executive Team , Boehringer Ingelheim , Stryker Corporation , Product Development , Juno Therapeutics Bristol Myers Squibb Partnership , Innovation Centre ,